Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other 1

Conditions

Carcinoma, Non-Small-Cell Lung 36Lung Neoplasms 7Brain Neoplasms 3Thyroid Neoplasms 2Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Thyroid Cancer, Papillary 1Thoracic Neoplasms 1Sexual Dysfunction, Physiological 1Sarcoma 1Salivary Gland Neoplasms 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neuroendocrine Tumors 1Neoplasms by Site 1Multiple Endocrine Neoplasia Type 2a 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lung Diseases 1Intestinal Neoplasms 1Intestinal Diseases 1Head and Neck Neoplasms 1Genomic Instability 1Gastrointestinal Diseases 1Eunuchism 1Erectile Dysfunction 1Disease Resistance 1

Interventions

trametinib 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1alectinib 1Pemetrexed 1Paclitaxel 1Nivolumab 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Erectile Dysfunction × alectinib × Thoracic × Clear all
NCT06532149 2024-08-09

EROS

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
80 enrolled
OtherThoracic

Carcinoma, Non-Small-Cell Lung, Eunuchism, Erectile Dysfunction, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡